ClinicalThought

Share

Program Content

Activities

  • Oral SERD Adherence HR+/HER2- Breast Cancer
    The Pharmacist’s Role in Improving Medication Adherence to Oral SERD Therapy in HR+/HER2- Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 23, 2024

    Expires: February 22, 2025

Faculty

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
Assistant Adjunct Professor
UK College of Pharmacy
Lexington, Kentucky

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner